Hyperactivity in the Hypothalamic-Pituitary-Adrenal Axis: An Invisible Killer for Anxiety and/or Depression in
Lan-Shuan Feng1, Yi-Ming Wang1, Huan Liu1,2
1First Clinical Medical College, Shaanxi University of Chinese Medicine, 712046 Xianyang, Shaanxi, China.
Insights
The hypothalamic-pituitary-adrenal (HPA) axis plays a key role in managing stress and inflammation, offering potential therapeutic targets for patients with both coronary heart disease (CHD) and anxiety or depression.
Area of Science:
- Cardiovascular Medicine
- Neuroscience
- Endocrinology
Background:
- Comorbidity of anxiety or depression with coronary heart disease (CHD) presents a significant clinical challenge.
- The hypothalamic-pituitary-adrenal (HPA) axis is increasingly recognized for its role in mediating the interplay between stress, inflammation, and cardiovascular health.
Purpose of the Study:
- To review the relevance of HPA axis activity in the context of cardiovascular and nervous systems.
- To explore the mechanisms by which HPA axis function influences neuroprotection and cardioprotection.
- To summarize the therapeutic potential of HPA axis modulation for comorbid CHD and anxiety or depression.
Main Methods:
- Literature review of recent studies on HPA axis activity.
- Analysis of HPA axis mechanisms in regulating inflammatory factors, oxidative stress, platelet activation, and gut microbiota.
- Synthesis of research on neuroprotective and cardioprotective benefits.
Main Results:
- HPA axis activity influences inflammatory factors, oxidative stress, platelet activation, and gut microbiota.
- These regulatory functions contribute to neuronal and endothelial cell survival and regeneration.
- The HPA axis demonstrates neuroprotective and cardioprotective effects.
Conclusions:
- HPA axis function is integral to the neuro-cardiovascular system.
- Modulating HPA axis activity holds therapeutic potential for managing comorbid CHD and anxiety or depression.
- HPA axis function may serve as a valuable biomarker for this patient population.
Abstract:
The coexistence of anxiety or depression with coronary heart disease (CHD) is a significant clinical challenge in cardiovascular medicine. Recent studies have indicated that hypothalamic-pituitary-adrenal (HPA) axis activity could be a promising focus in understanding and addressing the development of treatments for comorbid CHD and anxiety or depression. The HPA axis helps to regulate the levels of inflammatory factors, thereby reducing oxidative stress damage, promoting platelet activation, and stabilizing gut microbiota, which enhance the survival and regeneration of neurons, endothelial cells, and other cell types, leading to neuroprotective and cardioprotective benefits. This review addresses the relevance of the HPA axis to the cardiovascular and nervous systems, as well as the latest research advancements regarding its mechanisms of action. The discussion includes a detailed function of the HPA axis in regulating the processes mentioned. Above all, it summarizes the therapeutic potential of HPA axis function as a biomarker for coronary atherosclerotic heart disease combined with anxiety or depression.
Related Concept Videos
Hypothalamic-Pituitary Axis
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Generalized Anxiety Disorder


